3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
8
fludarabine
7
pembrolizumab
6
aldesleukin
4
Interleukin-2
3
spartalizumab
2
fludarabine phosphate
2
entinostat
2
Vorinostat
2
Trastuzumab
2
Nivolumab
2
Erlotinib Hydrochloride
2
Biopsy
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
tislelizumab
1
tipifarnib
1
prexasertib
1
oncogene protein E7, Human papillomavirus type 16
1
nanocis
1
enzalutamide
1
cemiplimab
1
bintrafusp alfa protein, human
1
atezolizumab
1
abiraterone
1
Tomography, X-Ray Computed
1
Thalidomide
1
Technetium-99
1
Taxes
1
SRA737
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Radionuclide Imaging
×
Head & Neck
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled